Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1989 1
1990 1
1992 1
1994 1
1996 1
2000 1
2006 1
2007 1
2011 1
2012 1
2017 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Cystic fibrosis: nutrition.
Durie PR, Pencharz PB. Durie PR, et al. Br Med Bull. 1992 Oct;48(4):823-46. doi: 10.1093/oxfordjournals.bmb.a072580. Br Med Bull. 1992. PMID: 1458303 Review.
Undernutrition, with loss of energy stores and lean tissue may in turn contribute to progressive deterioration of lung function. When this occurs, long-term invasive methods of nutritional support can restore energy balance....
Undernutrition, with loss of energy stores and lean tissue may in turn contribute to progressive deterioration of lung function. When this o …
Pathogenesis of malnutrition in cystic fibrosis, and its treatment.
Pencharz PB, Durie PR. Pencharz PB, et al. Among authors: durie pr. Clin Nutr. 2000 Dec;19(6):387-94. doi: 10.1054/clnu.1999.0079. Clin Nutr. 2000. PMID: 11104588 Review.
Our target is to achieve a completely normal nutritional status. Long term follow-up of these patients has shown significantly better survival in patients who achieve normal nutritional status. ...
Our target is to achieve a completely normal nutritional status. Long term follow-up of these patients has shown significantly better …
Vitamin K and the management of patients with cystic fibrosis.
Durie PR. Durie PR. CMAJ. 1994 Oct 1;151(7):933-6. CMAJ. 1994. PMID: 7922929 Free PMC article. Review.
In addition, various factors--including pancreatic failure, liver disease, bowel resection and long-term use of antibiotics--can put some of these patients at risk of vitamin K deficiency. ...
In addition, various factors--including pancreatic failure, liver disease, bowel resection and long-term use of antibiotics--can put …
The ontogeny of serum immunoreactive pancreatic lipase and cationic trypsinogen in the premature human infant.
Cleghorn G, Durie P, Benjamin L, Dati F. Cleghorn G, et al. Among authors: durie p. Biol Neonate. 1988;53(1):10-6. doi: 10.1159/000242756. Biol Neonate. 1988. PMID: 3355866
In the preterm infant, serum lipase was also significantly lower than values obtained at term (p less than 0.001). At birth, serum trypsinogen for preterm (16.8 +/- 1.3 micrograms/l) and term infants (23.3 +/- 1.9 micrograms/l) were below those for older chil …
In the preterm infant, serum lipase was also significantly lower than values obtained at term (p less than 0.001). At birth, s …
Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
Ooi CY, Sutherland R, Castellani C, Keenan K, Boland M, Reisman J, Bjornson C, Chilvers MA, van Wylick R, Kent S, Price A, Mateos-Corral D, Hughes D, Solomon M, Zuberbuhler P, Brusky J, Durie PR, Ratjen F, Gonska T. Ooi CY, et al. Among authors: durie pr. BMC Pediatr. 2019 Oct 22;19(1):369. doi: 10.1186/s12887-019-1756-4. BMC Pediatr. 2019. PMID: 31640630 Free PMC article.
CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive inconclusive diagnosis (CFSPID). These infants have an uncertain long-term outcome and it is currently unclear around time of diagnosis, which infants are at higher risk o …
CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive inconclusive diagnosis (CFSPID). These …
Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
Beharry S, Ackerley C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Beharry S, et al. Among authors: durie pr. Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G839-48. doi: 10.1152/ajpgi.00582.2005. Epub 2006 Nov 9. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17095751 Free article.
We used a congenic C57Bl/6J cystic fibrosis transmembrane conductance regulator (Cftr)(-/-) mouse model, which develops cystic fibrosis (CF)-like pathology in all organs, to evaluate the short- and long-term therapeutic effects of dietary docosahexaenoic acid (DHA). Thirty …
We used a congenic C57Bl/6J cystic fibrosis transmembrane conductance regulator (Cftr)(-/-) mouse model, which develops cystic fibrosis (CF) …
Phenotypic abnormalities in long-term surviving cystic fibrosis mice.
Kent G, Oliver M, Foskett JK, Frndova H, Durie P, Forstner J, Forstner GG, Riordan JR, Percy D, Buchwald M. Kent G, et al. Among authors: durie p. Pediatr Res. 1996 Aug;40(2):233-41. doi: 10.1203/00006450-199608000-00008. Pediatr Res. 1996. PMID: 8827771
Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel.
Durie P, Baillargeon JD, Bouchard S, Donnellan F, Zepeda-Gomez S, Teshima C. Durie P, et al. Curr Med Res Opin. 2018 Jan;34(1):25-33. doi: 10.1080/03007995.2017.1389704. Epub 2017 Oct 25. Curr Med Res Opin. 2018. PMID: 28985688
Pancreatic enzyme replacement therapy (PERT) can relieve symptoms and long-term sequelae of PEI. Diagnosis of PEI and initiation of PERT are usually the responsibility of gastroenterology specialists. However, primary care physicians (PCPs) are well positioned to identify …
Pancreatic enzyme replacement therapy (PERT) can relieve symptoms and long-term sequelae of PEI. Diagnosis of PEI and initiation of P …
Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome.
Koletzko S, Corey M, Ellis L, Spino M, Stringer DA, Durie PR. Koletzko S, et al. Among authors: durie pr. J Pediatr. 1990 Nov;117(5):815-22. doi: 10.1016/s0022-3476(05)83350-5. J Pediatr. 1990. PMID: 2231217 Clinical Trial.
In comparison with unselected patients with cystic fibrosis and pancreatic insufficiency who were receiving enzyme supplements and who had no distal intestinal obstruction, fecal fat losses (percentage of intake) were almost twice as high in the study group with DIOS (31.2 +/- 20 …
In comparison with unselected patients with cystic fibrosis and pancreatic insufficiency who were receiving enzyme supplements and who had n …
12 results